NEW YORK (GenomeWeb News) – German biotech firm MorphoSys today announced an agreement between its recently acquired subsidiary Sloning BioTechnology and Pfizer for use of Sloning's synthetic biology technology.
Get the full story
This story is free
for registered users
Registering provides access to this and other free content.
Register now.Already have an account?
Login Now.